Barriers to Care for Chronic Hepatitis C in the Direct-Acting Antiviral Era: A Single-Centre Experience

BMJ Open Gastroenterology- United Kingdom

doi 10.1136/bmjgast-2017-000181

Full Text

Abstract

Available in

Categories

Gastroenterology

Date

December 1, 2017

Authors

Lee Ann Yasukawa

Mindie H Nguyen

Publisher

BMJ

Related search

Oral Direct-Acting Antiviral Therapy for Hepatitis C

Journal of Antivirals & Antiretrovirals

English

Systematic Review: Current Concepts and Challenges for the Direct-Acting Antiviral Era in Hepatitis C Cirrhosis

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Digestive Diseases and Sciences

Gastroenterology

English

Early Outcomes Using Hepatitis C-Positive Donors for Cardiac Transplantation in the Era of Effective Direct-Acting Antiviral Treatments

Journal of Cardiac Failure

Cardiovascular Medicine

English

Direct-Acting Antiviral Drugs and Hepatitis C Virus: A Therapeutic Revolution?

Cancer Research

English

Treatment of the Chronic Hepatitis C Complicated by Mixed Cryoglobulinemia With Direct-Acting Antiviral Agents

Jurnal Infektologii

Infectious Diseases

English

Concerns About Direct-Acting Antiviral Agents for Hepatitis C—Cause for Reassurance

JAMA network open

English

Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents

Biology of Blood and Marrow Transplantation

Transplantation

English

Make Platelet Count Great Again: Direct‐acting Antiviral Agent Therapy in Patients With Chronic Hepatitis C

Advances in Digestive Medicine

English